Skip to main content
Clinical Trials/NCT03600740
NCT03600740TerminatedNot Applicable

Advancing Pre-operative Targeting for Deep Brain Stimulation in the Globus Pallidus Internus: Functional Segmentation Based on Probabilistic Tractography

Mayo Clinic3 sites in 1 country1 target enrollmentStarted: August 17, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
1
Locations
3
Primary Endpoint
Change in Unified Parkinson's Disease Rating Scale III (UPDRS-III)

Study Overview

Brief Summary

In the proposed pilot project, MRI data will be prospectively collected to show the feasibility of the segmentation algorithm and the potential relation to final lead positioning. Patients will be selected from those undergoing GPi DBS placement. This pilot data will serve as a basis for pursuing funding for a larger trial evaluating the prospective ability of the 3T targeting study to improve outcomes and decrease complications in GPi DBS placement. Improved outcomes and patient experience would be expected to further contribute to our facility as a center of excellence for treatment of movement disorders.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient with the diagnosis of Parkinson's Disease selected for placement of globus pallidus internus (GPi) deep brain stimulator (DBS)

Exclusion Criteria

  • Not provided

Arms & Interventions

GPi DBS

Experimental

Patients selected to undergo GPi DBS placement will be eligible for enrollment in the study. In addition to standard-of-care tests, subjects will undergo an MRI consisting of the proposed novel imaging protocol prior to placement of DBS. The patient will subsequently undergo standard-of-care therapy for DBS placement. Once the stimulator has been programmed post-operatively, the stimulation parameters and corresponding clinical changes will be collected and used to model the volume of activated tissue. The patient will additionally undergo a follow-up MRI used to localize the electrode within the brain to further localize the volume of activated tissue.

Intervention: DBS Programming (Device)

Outcomes

Primary Outcomes

Change in Unified Parkinson's Disease Rating Scale III (UPDRS-III)

Time Frame: 3 months

Pre-operative and post-operative UPDRS-III will be assessed to measure symptom improvement and correlated with imaging data.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Erik H. Middlebrooks, M.D.

Assistant Professor, Radiology and Neurosurgery

Mayo Clinic

Study Sites (3)

Loading locations...

Similar Trials